Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 9Head and Neck Neoplasms 9Carcinoma, Squamous Cell 3Neoplasms 2Carcinoma 2Tongue Neoplasms 1Thyroid Neoplasms 1Salivary Gland Malignancy 1Recurrence 1Neoplasm Metastasis 1Lung Neoplasms 1Histiocytosis 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Adenosquamous 1Brain Neoplasms 1Advanced Head and Neck Squamous Cancer 1

Interventions

Cetuximab 16Cisplatin 15Radiotherapy, Intensity-Modulated 10Radiotherapy 6Docetaxel 6Erlotinib Hydrochloride 5Fluorouracil 4Everolimus 4Carboplatin 4Sorafenib 3Radiation 3Paclitaxel 3Fluorodeoxyglucose F18 3Chemotherapy, Adjuvant 3Biopsy 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Taxes 2Sirolimus 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Platinum 2Photochemotherapy 2Microarray Analysis 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Gene Expression Profiling 2Drug Therapy 2Celecoxib 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tongue Neoplasms × Panitumumab × Head & Neck × Clear all
NCT01142414 2012-01-16

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡